Results 141 to 150 of about 19,294 (217)

Genomic Characterization of Yersinia enterocolitica Isolates, Costa Rica. [PDF]

Emerg Infect Dis
Savin C, Oropeza G, Barboza Fallas LA, Rivas-Solano O, Chanto G, Pizarro-Cerdá J.   +5 more
europepmc   +1 more source

Yersinia enterocolitica

Pediatrics In Review, 2005
openaire   +2 more sources

Temperature Adaptive Biofilm Formation in <i>Yersinia enterocolitica</i> in Response to pYV Plasmid and Calcium. [PDF]

Antibiotics (Basel)
Oh Y, Kim TJ.
europepmc   +1 more source

Zoonotic <i>Yersinia enterocolitica</i> in Swine: One Health Implications for Food Safety and Public Health. [PDF]

Vet Sci
Saraiva S, García-Díez J, de Sousa T, Calouro R, Fernandes D, Mourão AV, Saraiva C, Mesquita JR, Coelho AC, Poeta P.   +9 more
europepmc   +1 more source

In-host evolution of Yersinia enterocolitica during a chronic human infection. [PDF]

Nat Commun
Savin C, Lê-Bury P, Guglielmini J, Douché T, Mas Fiol G, Buzelé R, Le Brun C, Bastides F, François M, Birmelé B, Guichard L, Madej J, Beau R, Cabanel N, Dortet L, Matondo M, Dussurget O, Carniel E, Lanotte P, Pizarro-Cerdá J.   +19 more
europepmc   +1 more source

The Gene Ail for the Attachment-Invasion Locus Protein of <i>Yersinia enterocolitica</i> Biotype 1A Strains Is Located on the Genomes of Novel Prophages. [PDF]

Int J Mol Sci
Hammerl JA, Hertwig S.
europepmc   +1 more source

Biotype Determines Survival of <i>Yersinia enterocolitica</i> in Red Blood Cell Concentrates. [PDF]

Int J Mol Sci
Morka K, Banaszkiewicz S, Korkus J, Bania J, Bystroń J, Bugla-Płoskońska G, Stanek M, Sokalska U, Szymczyk-Nużka M, Sheppard SK, Pascoe B.   +10 more
europepmc   +1 more source

Proteome mining of Yersinia Enterocolitica for drug targets and computational inhibitor identification with ADMET, anti-inflammation potential and formulation characteristics. [PDF]

BioData Min
Basharat Z, Alghamdi YS, Mashraqi MM, Ogaly HA, Al-Zahrani FAM, Wei CR, Ahmed I, Kim S.   +7 more
europepmc   +1 more source

Selective Inhibition of <i>Yersinia enterocolitica</i> Type III Secretion by <i>Lindera obtusiloba</i> Extract and Cinnamtannin B1. [PDF]

Pharmaceutics
Yoo JH, Kim TJ.
europepmc   +1 more source

Screening of novel therapeutic targets and chimeric vaccine construction against antibiotic-resistant <i>Yersinia Enterocolitica</i>. [PDF]

Front Immunol
Shah M, Fatima R, Sarfraz A, Khan MU, Ejaz H, Alam M, Aziz S, Nishan U, Ali A, Bari A, Ojha SC.   +10 more
europepmc   +1 more source